How to start a hair loss telehealth brand
The longest proof cycle in telehealth. A patient decides whether to keep paying months before the therapy can possibly show a result, which makes this a retention design problem first.
Key takeaways
- Visible results take three to six months. The patient's churn decision comes first, so the product has to bridge the gap.
- The intake photo is a retention asset, not paperwork. At month four it is the only evidence of progress the patient has.
- Almost all churn happens between month three and month five, and it is a product problem rather than a marketing one.
- Price twelve and twenty-four week commitments so the longer term is the rational choice.
- Male and female protocol lines differ in formulation and should be configured independently.
The structural problem
Hair loss has the worst mismatch in telehealth between when the patient pays and when the patient can tell whether it worked. Three to six months of paying precede any visible change.
That means the business is not won on acquisition or on clinical outcome. It is won on whether the patient is still subscribed at month six. Everything else is secondary to that single number.
Photos do double duty
Clinically, baseline photographs give the reviewing provider a pattern and a reference point to assess against at later check-ins.
Commercially, they are the only thing that will convince a patient at month four that something is happening. Nobody can see incremental regrowth in a mirror they look at daily. Almost anybody can see it against a photograph taken sixteen weeks earlier.
A brand that captures photos at intake and surfaces the comparison in the portal has a retention mechanism its competitors do not, built from something it was collecting anyway.
Price the commitment, not the product
Monthly billing gives the patient a cancellation decision every thirty days for the entire period in which the therapy cannot yet be seen to work. That is the worst possible cadence for this category.
Four, twelve and twenty-four week supply options, priced so the longer term is obviously more rational per month, align the billing cycle with the clinical one and carry the patient past the point where they would otherwise quit.
This is discounting the commitment rather than discounting the product, which matters: the first buys retention, the second trains patients to wait for a sale.
Two protocol lines, configured separately
Male and female regimens differ in formulation, not merely in marketing. Finasteride and dutasteride appear in male lines; spironolactone appears in female protocols. Topical combinations, oral formulations and combined regimens all sit alongside each other.
Running them as one product with a gender field produces the wrong intake questions and the wrong catalog. Configured independently, each line gets its own screening, its own formulary and its own messaging.
Where the churn actually comes from
It is worth being precise about this, because the instinct is to blame the offer or the price when the causes are almost always operational.
- No visible progress, addressed by photo comparison in the portal.
- No reassurance, addressed by provider check-ins telling the patient whether what they are seeing is normal.
- Expired cards on a long subscription, addressed by account updater coverage and self-serve card updates.
- A monthly cadence that invites a decision too often, addressed by longer supply commitments.
Photo intake, long cycles, and a portal built for month four
PharmaBro supports photo-supported intake with asynchronous provider review, separate male and female protocol lines, and four, twelve and twenty-four week supply options billed on fulfillment rather than a calendar.
The patient portal carries the progress comparison, the next shipment, provider messaging and self-serve card updates, under your brand on your domain.
Conclusion
Hair loss is a retention business wearing an acquisition business's clothes.
Capture the baseline photo, price the longer commitment, keep a provider in the loop for reassurance rather than only for prescribing, and remove every avoidable cause of involuntary churn. The clinical part is comparatively easy; getting the patient to month six is the product.
Frequently asked questions
Do hair loss patients need a video visit?
No. Asynchronous review with photo support, which keeps acquisition cost low in a category where the payback period is already long.
How should I price a hair loss subscription?
Discount the longer commitments meaningfully. The therapy needs three to six months to show a result, and a monthly plan invites the patient to quit before it does. Twelve and twenty-four week supplies priced clearly below the monthly equivalent align the billing cycle with the clinical one.
What formulations can I offer?
Compounded topical combinations of minoxidil with finasteride, dutasteride, tretinoin or fluocinolone, oral formulations, and female-specific protocols including spironolactone. Male and female lines should be configured independently.
References
Tobias LundHead of Growth
Came from performance marketing on the brand side. Now spends his time explaining why blended CAC is the only acquisition number that does not lie to you.